// App-Quantinova.ai

909-03 : APIXABAN REDUCES HOSPITALIZATIONS IN PATIENTS WITH VTE: AN ANALYSIS OF THE AMPLIFY TRIAL

Researchers

Presenter

  • Xianchen Liu

Principal Investigators

  • Margot Johnson

  • Jack Mardekian

  • Hemant Phatak

  • John Thompson

  • Alexander Cohen

Medical Centers

  • Kings College London, London, United Kingdom

Locations

  • United Kingdom

Companies

  • Pfizer Inc.

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

  • Deep vein thrombosis

  • Pulmonary embolism

Biomarkers

  • N/A

Drug/Treatment

  • Enoxaparin

  • Enoxaparin sodium

  • apixaban

  • Warfarin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved